Showing results (921-930 of 1,007) with videos related to

Sort By:
Pageof 101
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2022
Antitumor Activity of Lurbinectedin, a Selective Inhibitor of Oncogene Transcription, in Patients with Relapsed Ewing Sarcoma: Results of a Basket Phase II StudyVivek Subbiah, Irene Braña, Alessandra Longhi, et al.
JCO Precision Oncology|September 28, 2022
Circulating Tumor DNA After Neoadjuvant Chemotherapy in Breast Cancer Is Associated With Disease RelapseFrédéric Cailleux, Elisa Agostinetto, Matteo Lambertini, et al.
BMC Cancer|April 17, 2013
Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric studyAlain Hendlisz, Vassilis Golfinopoulos, Amelie Deleporte, et al.
JAMA Oncology|April 15, 2016
Neratinib Plus Paclitaxel vs Trastuzumab Plus Paclitaxel in Previously Untreated Metastatic ERBB2-Positive Breast Cancer: The NEfERT-T Randomized Clinical TrialAhmad Awada, Ramon Colomer, Kenichi Inoue, et al.
Research Square|March 22, 2023
Novel Scheme for Defining the Clinical Implications of TP53 Mutations in Myeloid NeoplasiaWaled Bahaj, Tariq Kewan, Carmelo Gurnari, et al.
Cells|January 24, 2025
Flow Cytometry Evaluation of Blood-Cell-Bound Surface FVIII in Hemophilia A and ThrombosisAnjud Al-Mohannadi, Reem Mohammed Yahia, Hani Bibawi, et al.
British Journal of Haematology|January 21, 2020
Large granular lymphocytic leukaemia after solid organ and haematopoietic stem cell transplantationHassan Awada, Reda Z Mahfouz, Jibran Durrani, et al.
British Journal of Cancer|November 24, 2020
A first-in-man phase 1 study of the DNA-dependent protein kinase inhibitor peposertib (formerly M3814) in patients with advanced solid tumoursMark T J van Bussel, Ahmad Awada, Maja J A de Jonge, et al.
Blood Advances|June 16, 2023
Applicability of 2022 classifications of acute myeloid leukemia in the real-world settingEnrico Attardi, Arianna Savi, Beatrice Borsellino, et al.
Journal of Hematology & Oncology|August 3, 2023
Novel scheme for defining the clinical implications of TP53 mutations in myeloid neoplasiaWaled Bahaj, Tariq Kewan, Carmelo Gurnari, et al.
Pageof 101